(Q33591485)

28 July 2017

1 reference

title

Maintaining and enhancing vaccine immunogenicity (English)

1 reference

28 July 2017

Gradon JD

1

1 reference

PubMed ID

10198791

28 July 2017

Lutwick LI

series ordinal

2

1 reference

28 July 2017

1 March 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

1

1 reference

28 July 2017

39-60, vi

1 reference

Efficacy of a food plant-based oral cholera toxin B subunit vaccine

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

The immunotargeting approach to adjuvant-independent subunit vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

A new family of carriers (biovectors) enhances the immunogenicity of rabies antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

The biology of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

European Commission COST/STD Initiative. Report of the expert panel VII. Vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Anti-oxidants inhibit the enhancement of the immune response caused by oil adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Clinical immunogenicity and tolerance studies of liquid vaccines delivered by jet-injector and a new single-use cartridge (Imule): comparison with standard syringe injection. Imule Investigators Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Cold chain in a hot climate

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Oral immunization with a recombinant bacterial antigen produced in transgenic plants.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Is the cold chain for vaccines maintained in general practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Validation of cold chain procedures suitable for distribution of vaccines by public health programs in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Cytokines as adjuvants for ruminant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

The chameleon within: improving antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Expression of hepatitis B surface antigen in transgenic plants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Hepatitis B vaccine administration: comparison between jet-gun and syringe and needle

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Regulation of the immune response by the major histocompatibility system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Expression of the rabies virus glycoprotein in transgenic tomatoes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Immunization against rabies with plant-derived antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Recent advances in vaccine adjuvants for systemic and mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Preparation and characterization of a biodegradable microparticle antigen/cytokine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Human TH1 and TH2 subsets: doubt no more

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

No local skin sensitization by repeated tuberculin test

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

New use of BCG for recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Nonreplicating vaccinia vector efficiently expresses recombinant genes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Vaccination onto bare skin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Immunogenicity of transgenic plant-derived hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Regulation of cytokine gene expression by adjuvants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Electronic monitoring of vaccine cold chain in a metropolitan area

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

Human adenovirus type 5 vectors expressing rabies glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970042-8

7 January 2021

10.1016/S0891-5520(05)70042-8

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10198791